Adapting the Tumor Board Model for Mental Illness and Cancer

Study summary

This study examines the feasibility and acceptability of a virtual tumor board for cancer and mental illness for patients with serious mental illness and a new cancer diagnosis. The study also examines the impact on patient care, psychiatric symptoms, and clinician self-efficacy in managing this population.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedVirtual Cancer and Mental Health Tumor Board

The study team can explain what participation involves.

Who it may be forCancer · Severe Major Depression

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 3, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Massachusetts General Hospital
Interventions being studied: Behavioral: Virtual Cancer and Mental Health Tumor Board

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Age ≥ 18 years old 2. Verbal fluency in English 3. SMI (schizophrenia spectrum disorder, bipolar disorder, or major depressive disorder with either prior psychiatric hospitalization, history of suicide attempt/suicidal ideation, Medicaid insurance, and/or comorbid alcohol or opioid use disorder) confirmed by diagnostic evaluation of study psychiatrist 4. New invasive stage I-IV breast, lung, gastrointestinal, genitourinary, or head and neck cancer (highly suspected or confirmed according to documentation by the oncologist or pathology) 5. Oncology consultation at or referral to a MGH Danvers within the past 8 weeks

Reasons someone may not be able to joinExclusion criteria

1. Have cognitive impairment severe enough to interfere with completing brief study assessments or providing informed consent and does not have a guardian who can provide consent 2. Recurrence of same cancer type 3. Do not have verbal fluency in English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mass General/North Shore Center for Outpatient CareDanvers, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 3, 2023. Always confirm current availability with the study team.

View original record ↗